With new rapid test, Sorrento expands COVID portfolio July 29, 2020 By Alfred Romann No Comments VANCOUVER – Sorrento Therapeutics Inc., which is working to build a comprehensive lineup of COVID-19 products, has in-licensed a self-contained test for SARS-CoV-2 that may produce accurate results in half an hour. Read More